

[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI

[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
Douglas Tsao Reiterated (VRDN) at Strong Buy and Held Target at $37 on, Feb 29th, 2024
Douglas Tsao of HC Wainwright & Co., Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $37 on, Feb 29th, 2024.
Douglas has made no other calls on VRDN in the last 4 months.
There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Douglas's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Douglas
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $30 on, Wednesday, February 28th, 2024
- Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $36 on, Tuesday, December 19th, 2023
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023
- Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 14th, 2023
Contributing Sources